Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 11, 2006, Pages 1279-1281

  Chamorro, A ^a   Amaro, S ^a   Vargas, M ^a   Obach, V ^a   Cervera, A ^a   Torres, F ^b   Planas, A M ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 33750478991     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.100800     Document Type: Article

References (17)

1. Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke. Implications for neurological intensive care medicine. Stroke 2003;34:975-81.
2. Langhorne V, Statt DJ, Robertson L, et al. Medical complications after stroke: a multicenter study. Stroke 2000;31:1223-9.
3. Vargas M, Horcajada JP, Obach V, et al. Clinical consequences of infection in patients with acute stroke. Is it prime time for further antibiotic trials? Stroke 2000;37:461-5.
4. Grau AJ, Buggle F, Schnitzler P, et al. Fever and infection early after ischemic stroke. J Neurol Sci 1999;171:115-20.
5. Chamorro A, Horcajada JP, Obach V, et al. The early systemic prophylaxis of infection after stroke study: a randomized clinical trial. Stroke 2005;36:1495-500.
6. Prass K, Meisel C, Höflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003;198:725-36.
7. Howard RJ, Simmons RL. Acquired immunologic deficiencies after trauma and surgical procedures. Surg Gynecol Obstet 1974;139:771-82.
8. Vila N, Castillo J, Davalos A, et al. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003;34:671-5.
9. Vila N, Filella X, Deulofeu R, et al. Cytokine-induced inflammation and long-term stroke functional outcome. J Neurol Sci 1999;162:185-8.
10. Besedovsky H, del Rey A, Sorkin E, et al. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986;233:652-4.
11. Elenkov U, Wilder R, Chrousos GP, et al. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.
12. Woiciechowsky C, Schöning B, Lanksch WR, et al. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med 1999;77:769-80.
13. Johnston KC, Li JY, Lyden PD, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTTAS trial. Stroke 1998;29:447-53.
14. Akdis CA, Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 2001;103:131-6.
15. Friedman G, Jankowski S, Marchant A, et al. Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 1997;12:183-7.
16. O'Farrell AM, Liu Y, Moore KW, et al. IL-10 inhibits macrophage activation and proliferation by distinct signalling mechanisms: evidence for Stat3-dependent and independent pathways. EMBO J 1998;16:1006-18.
17. Gerard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-50.